[pfisherman]

> None of these require gain of function research.

Please elaborate on this. How should I go about anticipating which mutations in which genes / protein will result in resistance to a candidate therapy / molecule / mechanism that I am considering advancing into phase 1 trials?

[PM_me_your_math]

It is dangerous to play bio-engineer, and then handle what you create like Gomer Pyle.